Deciduous

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Rubedo.Life

This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.

Cleara Biotech

The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

Rubedo

This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.

HexemBio

This company develops stem cell rejuvenation therapies using synthetic environments to treat blood cancer and age-related immune decline in human patients.

BioAge Labs

This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.